Crispr Therapeutics (CRSP) announced that its COO, Julianne Bruno, will be stepping down from the company to pursue external opportunities, effective as of April 11.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CRSP:
- Buy Rating for Crispr Therapeutics AG Driven by Promising Clinical Data and Diversified Pipeline
- Cathie Wood’s ARK Invest Snaps Up Tesla Stock (TSLA) amid 42% Price Drop
- Cathie Wood Loads up on COIN and HOOD Stocks but Sells $13M Worth PATH Stock
- Unusually active option classes on open February 18th
- Crispr Therapeutics price target lowered to $82 from $89 at Citi